Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

The optimal follow-up period in patients with above 5-year disease-free survival after curative liver resection for hepatocellular carcinoma.

Ahn SH, Kim SH, Choi GH, Choi JS, Kim KS.

J Korean Surg Soc. 2013 Dec;85(6):269-74. doi: 10.4174/jkss.2013.85.6.269. Epub 2013 Nov 26.

2.

Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.

Yang W, Chen MH, Yin SS, Yan K, Gao W, Wang YB, Huo L, Zhang XP, Xing BC.

AJR Am J Roentgenol. 2006 May;186(5 Suppl):S275-83.

PMID:
16632688
3.
4.

Prognosis and results after resection of very large (>or=10 cm) hepatocellular carcinoma.

Shah SA, Wei AC, Cleary SP, Yang I, McGilvray ID, Gallinger S, Grant DR, Greig PD.

J Gastrointest Surg. 2007 May;11(5):589-95.

PMID:
17393258
5.

Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.

Zhao WH, Ma ZM, Zhou XR, Feng YZ, Fang BS.

World J Gastroenterol. 2002 Apr;8(2):237-42.

6.

[Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].

Yang W, Chen MH, Yan K, Gao W, Yin SS, Wang YB, Zhang XP, Xing BC, Huang XF.

Zhonghua Wai Ke Za Zhi. 2005 Aug 1;43(15):980-4. Chinese.

PMID:
16194353
7.

Clinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period).

Wahab MA, El Hanafy E, El Nakeeb A, Ali MA.

World J Gastrointest Surg. 2017 Feb 27;9(2):61-67. doi: 10.4240/wjgs.v9.i2.61.

8.

Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.

Techathuvanan K, Srisajjakul S, Pongpaibul A, Limsrichamrern S, Charatcharoenwitthaya P, Chainuvati S, Tanwandee T, Chotiyaputta W.

J Med Assoc Thai. 2015 Apr;98(4):334-42.

PMID:
25958707
10.

Laparoscopic liver resection: 5-year experience at a single center.

Long TC, Bac NH, Thuan ND, Dat le T, Viet DQ, Chuong le CH.

Surg Endosc. 2014 Mar;28(3):796-802. doi: 10.1007/s00464-013-3259-y. Epub 2013 Nov 7.

11.

HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.

Sohn W, Paik YH, Kim JM, Kwon CH, Joh JW, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Ann Surg Oncol. 2014 Jul;21(7):2429-35. doi: 10.1245/s10434-014-3621-x. Epub 2014 Mar 12.

PMID:
24619495
12.

Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.

Mikami S, Tateishi R, Akahane M, Asaoka Y, Kondo Y, Goto T, Shiina S, Yoshida H, Koike K.

J Vasc Interv Radiol. 2012 Oct;23(10):1269-75. doi: 10.1016/j.jvir.2012.06.032.

PMID:
22999746
13.

Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.

Minagawa M, Makuuchi M, Takayama T, Kokudo N.

Ann Surg. 2003 Nov;238(5):703-10.

14.

Longterm prognosis after hepatic resection for small hepatocellular carcinoma.

Shimozawa N, Hanazaki K.

J Am Coll Surg. 2004 Mar;198(3):356-65.

PMID:
14992736
15.

Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.

Hu RH, Ho MC, Wu YM, Yu SC, Lee PH.

Clin Transplant. 2005 Apr;19(2):175-80.

PMID:
15740552
17.

A scoring system for prediction of early recurrence after liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.

Qian H, Wei M, Qiu H, Wu J, Liu B, Lyu A, Liu Q, Li C, Leng J, Zhang J, Hao C.

Chin Med J (Engl). 2014;127(24):4171-6.

PMID:
25533817
18.

Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.

Liu C, Sun L, Xu J, Zhao Y.

World J Surg Oncol. 2016 Apr 2;14:100. doi: 10.1186/s12957-016-0855-z.

19.

Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome.

Chen WT, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Wu CW.

Eur J Surg Oncol. 2004 May;30(4):414-20.

PMID:
15063895
20.

Sectionectomy is suitable for patients with T2 hepatocellular carcinoma according to the modified international union against cancer TNM Classification.

Ariizumi S, Katagiri S, Katsuragawa H, Kotera Y, Yamamoto M.

Dig Surg. 2007;24(5):342-8. Epub 2007 Sep 4.

Supplemental Content

Support Center